Same Drug Class

Nivolumab vs Tacrolimus

Nivolumab vs Tacrolimus: Overview

This comparison examines the pharmacological differences between Nivolumab and Tacrolimus.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Tacrolimus: Calcineurin inhibitor binding FKBP12; suppresses IL-2 transcription.

Pharmacokinetics

Half-life: Nivolumab — 27 days; Tacrolimus — 12 hours.

Chemical Properties

Molecular Formula: Tacrolimus — C44H69NO12.

Molecular Weight: Tacrolimus — 804.0180 g/mol.

Type: Nivolumab — Antibody; Tacrolimus — Small molecule.